ArticleNPJ systems biology and applications2025

Leveraging quantitative systems pharmacology modeling for elranatamab regimen optimization in relapsed or refractory multiple myeloma.

Kamrine E Poels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.